ZAC1 target genes and pituitary tumorigenesis
- PMID: 20117169
- DOI: 10.1016/j.mce.2010.01.033
ZAC1 target genes and pituitary tumorigenesis
Abstract
The zinc-finger protein Zac1 has a role as transcription factor and coregulator and plays an important role in pituitary development, maturation and tumorigenesis. Zac1 target genes control cell proliferation and hormone synthesis. While Zac1 is highly expressed in all hormone-producing cells of the pituitary, loss of expression frequently occurs in pituitary adenomas, in particular in non-functioning tumors. Zac1 lies downstream to the mitogenic MAPK and survival PI3K pathways. In turn, inhibition of the PI3K pathway by therapeutic agents, like somatostatin analogs up-regulate Zac1 expression. In fact Zac1 is an essential mediator of the antiproliferative effects of this treatment and correlates to successful outcome in acromegalic patients.
2010 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Zac1 functions through TGFbetaII to negatively regulate cell number in the developing retina.Neural Dev. 2007 Jun 8;2:11. doi: 10.1186/1749-8104-2-11. Neural Dev. 2007. PMID: 17559664 Free PMC article.
-
Regulation of apoptosis and cell cycle arrest by Zac1, a novel zinc finger protein expressed in the pituitary gland and the brain.EMBO J. 1997 May 15;16(10):2814-25. doi: 10.1093/emboj/16.10.2814. EMBO J. 1997. PMID: 9184226 Free PMC article.
-
ZAC1 and SSTR2 are downregulated in non-functioning pituitary adenomas but not in somatotropinomas.PLoS One. 2013 Oct 2;8(10):e77406. doi: 10.1371/journal.pone.0077406. eCollection 2013. PLoS One. 2013. PMID: 24098585 Free PMC article.
-
LOT1 (ZAC1/PLAGL1) and its family members: mechanisms and functions.J Cell Physiol. 2007 Jan;210(1):16-25. doi: 10.1002/jcp.20835. J Cell Physiol. 2007. PMID: 17063461 Review.
-
Novel pathway for somatostatin analogs in patients with acromegaly.Trends Endocrinol Metab. 2013 May;24(5):238-46. doi: 10.1016/j.tem.2012.11.007. Epub 2012 Dec 25. Trends Endocrinol Metab. 2013. PMID: 23270713 Review.
Cited by
-
Annotation of pituitary neuroendocrine tumors with genome-wide expression analysis.Acta Neuropathol Commun. 2021 Nov 10;9(1):181. doi: 10.1186/s40478-021-01284-6. Acta Neuropathol Commun. 2021. PMID: 34758873 Free PMC article.
-
Pasireotide: a novel treatment for patients with acromegaly.Drug Des Devel Ther. 2016 Jan 11;10:227-39. doi: 10.2147/DDDT.S77999. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 26811671 Free PMC article. Review.
-
The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly.Pituitary. 2016 Apr;19(2):210-21. doi: 10.1007/s11102-015-0677-y. Pituitary. 2016. PMID: 26290466 Free PMC article. Review.
-
Imprinted Genes and Multiple Sclerosis: What Do We Know?Int J Mol Sci. 2021 Jan 29;22(3):1346. doi: 10.3390/ijms22031346. Int J Mol Sci. 2021. PMID: 33572862 Free PMC article. Review.
-
Predictors of biochemical and structural response to medical therapy in patients with active acromegaly following surgery: a real-world perspective.BMC Endocr Disord. 2025 Feb 3;25(1):30. doi: 10.1186/s12902-025-01856-w. BMC Endocr Disord. 2025. PMID: 39901117 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases